Regulatory science: a special update from the United States Food and Drug Administration - Preclinical issues and status of investigation of botanical drug products in the United States

Author: Wu K.-M.   DeGeorge J.G.   Atrakchi A.   Barry E.   Bigger A.   Chen C.   Du T.   Freed L.   Geyer H.   Goheer A.   Jacobs A.   Jean D.   Rhee H.   Osterberg R.   Schmidt W.   Farrelly J.G.  

Publisher: Elsevier

ISSN: 0378-4274

Source: Toxicology Letters, Vol.111, Iss.3, 2000-01, pp. : 199-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract